Jpmorgan Chase & CO Veru Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Veru Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 63,190 shares of VERU stock, worth $261,606. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,190
Previous 255,782
75.3%
Holding current value
$261,606
Previous $166,000
81.93%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VERU
# of Institutions
135Shares Held
44.1MCall Options Held
50.5KPut Options Held
824K-
Black Rock Inc. New York, NY7.65MShares$31.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.41MShares$26.5 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.91MShares$20.3 Million0.56% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.62MShares$10.9 Million0.0% of portfolio
-
Ubs Group Ag1.65MShares$6.85 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $332M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....